Dashboard
Manage Tickers

JNJ


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
"Toxic Arsenic And Lead Commonly Found In ...
07/05/2024 14:45:31

https://nypost.com/2024/07/05/lifestyle/toxic-arsenic-and-lead-commonly-found-in-tampons-new-study/  

whats-going-on-with-johnson-and-johnson-shares-friday
What's Going On With Johnson and Johnson S...
07/05/2024 14:35:19

In the last week, Johnson and Johnson announced positive results from two clinical trials and authorization from Health Canada...

health-canada-authorizes-rybrevant-in-combination-with-carboplatin-and-pemetrexed-as-the-only-targeted-first-line-treatment-approved-for-patients-with-non-small-cell-lung-cancer-with-egfr-exon-20-insertion-mutations
Health Canada Authorizes RYBREVANT In Comb...
07/03/2024 12:04:29

Phase 3 PAPILLON study showed RYBREVANT® in combination with carboplatin and pemetrexed significantly improved progression-free...

johnson--johnsons-cell-therapy-carvykti-shows-better-survival-rate-in-pretreated-blood-cancer-patients
Johnson & Johnson's Cell Therapy Carvykti ...
07/02/2024 15:06:38

Johnson & Johnson announced Phase 3 CARTITUDE-4 study results showing Carvykti significantly improves overall survival in r...

court-rules-against-johnson--johnson-in-talcum-powder-cancer-study-case
Court Rules Against Johnson & Johnson In T...
07/02/2024 13:55:05

A federal judge has dismissed a Johnson & Johnson subsidiary's lawsuit against Dr. Jacqueline Moline, who linked talc p...

johnson--johnsons-second-interim-analysis-of-phase-3-cartitude-4-study-of-carvykti-vs-standard-therapies-for-relapsed-or-lenalidomide-refractory-multiple-myeloma-show-statistically-significant-clinically-meaningful-improvement-in-overall-survival
Johnson & Johnson's Second Interim Analysi...
07/02/2024 11:37:38

5-biggest-winners-5-biggest-losers-from-dow-jones-industrial-average-in-first-half-2024
5 Biggest Winners, 5 Biggest Losers From D...
07/01/2024 22:38:43

Ten of the Dow Jones Industrial Average stocks were up double digit percentage in the first half of 2024. A look at the best an...

assessing-johnson-amp-johnsons-performance-against-competitors-in-pharmaceuticals-industry
Assessing Johnson & Johnson's Performa...
07/01/2024 15:00:39

judge-blocks-cancer-victims-attempt-to-stop-johnson--johnson-bankruptcy-plan
Judge Blocks Cancer Victims' Attempt To St...
07/01/2024 14:25:53

A federal judge rejected a bid by cancer victims to block Johnson & Johnson from pursuing a $6.48 billion bankruptcy settle...

cantor-fitzgerald-reiterates-overweight-on-johnson--johnson-maintains-215-price-target
Cantor Fitzgerald Reiterates Overweight on...
07/01/2024 13:32:18

Cantor Fitzgerald analyst Louise Chen reiterates Johnson & Johnson (NYSE:JNJ) with a Overweight and maintains $215 price...

johnson--johnson-shares-results-from-the-nipocalimab-pivotal-phase-3-trial-demonstrating-longest-sustained-disease-control-in-fcrn-class-for-broadest-population-of-myasthenia-gravis-patients
Johnson & Johnson Shares Results From The ...
06/28/2024 15:31:38

First-and-only FcRn blocker to demonstrate superiority in activities of daily living (MG-ADLa) over placebo when added to stand...

jj-says-chmp-adopts-positive-opinion-for-balversa-erdafitinib-for-treatment-of-adult-patients
J&J Says CHMP Adopts Positive Opinion For ...
06/28/2024 14:58:23

- Reuters 

wall-streets-most-accurate-analysts-give-their-take-on-3-health-care-stocks-with-over-3-dividend-yields
Wall Street's Most Accurate Analysts Give ...
06/28/2024 11:30:58

Core News & Articles
CHMP Adopted Positive Opinion For Janssen...
06/28/2024 10:55:46

reported-earlier-supreme-court-blocks-purdue-pharmas-7-billion-bankruptcy-plan-impacting-jj-cases
Reported Earlier, Supreme Court Blocks Pur...
06/28/2024 07:05:37

The U.S. Supreme Court has denied a $7 billion Purdue Pharmaceuticals bankruptcy plan which would have given the Sackler family...

abbviegenmabs-epkinly-fda-approval-is-a-positive-step-analyst-says-additional-expansion-opportunities-underway
AbbVie/Genmab's Epkinly FDA Approval Is A ...
06/27/2024 17:22:09

The FDA has approved Epkinly as the first subcutaneously administered bispecific antibody for adults with relapsed or refractor...

sanofi-looks-to-sell-20b-icy-hot-division-likely-bidders-include-advent-pai-partners-blackstone-cvc
Sanofi Looks To Sell $20B Icy Hot Division...
06/26/2024 13:16:58

Sanofi wants $20 billion for its consumer health division, attracting interest from major firms like Advent and PAI Partners.

cantor-fitzgerald-reiterates-overweight-on-johnson--johnson-maintains-215-price-target
Cantor Fitzgerald Reiterates Overweight on...
06/25/2024 14:52:57

Cantor Fitzgerald analyst Louise Chen reiterates Johnson & Johnson (NYSE:JNJ) with a Overweight and maintains $215 price...

supreme-court-backs-pharmaceutical-giants-in-iraq-terrorism-funding-case
Supreme Court Backs Pharmaceutical Giants ...
06/24/2024 19:47:37

The U.S. Supreme Court supports pharmaceutical companies, led by AstraZeneca, in a lawsuit accusing them of funding terrorism i...

johnson--johnsons-options-a-look-at-what-the-big-money-is-thinking
Johnson & Johnson's Options: A Look at Wha...
06/24/2024 18:01:26

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)
07/23/2024 Fastly, Inc. (FSLY)
07/29/2024 Enphase Energy, Inc. (ENPH)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)